Search
Now showing items 1-1 of 1
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Fruchart, Jean-Charles et al. (2019)
Wissenschaftlicher Artikel